Clinical Trial
doi: 10.1016/s0140-6736(85)92559-0.
Oral immunisation with killed Haemophilus influenzae for protection against acute bronchitis in chronic obstructive lung disease
- PMID: 2867396
- DOI: 10.1016/s0140-6736(85)92559-0
Item in Clipboard
Clinical Trial
Oral immunisation with killed Haemophilus influenzae for protection against acute bronchitis in chronic obstructive lung disease
Lancet.
1985 Dec.
Abstract
Fifty patients with chronic obstructive lung disease were randomly allocated to three groups, to assess whether an oral vaccine containing non-typable Haemophilus influenzae protected against acute bronchitis. The double-blind prospective study over a three-month winter period included two placebo groups and one test group. Oral immunisation with H influenzae induced a tenfold reduction in the incidence of infection (p less than 0.001). During the subsequent winter, without further immunisation, protection by the vaccine was no longer statistically significant. There was no clear correlation between clinical protection and either carriage of H influenzae or the level of antibody to H influenzae antigen in saliva.
Similar articles
-
Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease.Cochrane Database Syst Rev. 2014 Sep 9;(9):CD010010. doi: 10.1002/14651858.CD010010.pub2. Cochrane Database Syst Rev. 2014. Update in: Cochrane Database Syst Rev. 2017 Jun 19;6:CD010010. doi: 10.1002/14651858.CD010010.pub3. PMID: 25201571 Updated. Review.
-
A controlled trial of a killed Haemophilus influenzae vaccine for prevention of acute exacerbations of chronic bronchitis.Aust N Z J Med. 1991 Aug;21(4):427-32. doi: 10.1111/j.1445-5994.1991.tb01346.x. Aust N Z J Med. 1991. PMID: 1953532 Clinical Trial.
-
Protection against recurrent acute bronchitis after oral immunization with killed Haemophilus influenzae.Med J Aust. 1990 Apr 16;152(8):413-6. doi: 10.5694/j.1326-5377.1990.tb125268.x. Med J Aust. 1990. PMID: 2184330 Clinical Trial.
-
Efficacy of oral immunization against non-typable Haemophilus influenzae in man.Int J Immunopharmacol. 1987;9(3):283-8. doi: 10.1016/0192-0561(87)90052-x. Int J Immunopharmacol. 1987. PMID: 3301699 Clinical Trial.
-
Haemophilus influenzae oral whole cell vaccination for preventing acute exacerbations of chronic bronchitis.Cochrane Database Syst Rev. 2003;(3):CD001958. doi: 10.1002/14651858.CD001958. Cochrane Database Syst Rev. 2003. Update in: Cochrane Database Syst Rev. 2006 Oct 18;(4):CD001958. doi: 10.1002/14651858.CD001958.pub2. PMID: 12917917 Updated. Review.
Cited by
-
Acute exacerbations in COPD and their control with oral immunization with non-typeable haemophilus influenzae.Front Immunol. 2011 Mar 15;2:7. doi: 10.3389/fimmu.2011.00007. eCollection 2011. Front Immunol. 2011. PMID: 22566798 Free PMC article.
-
Safety and immunogenicity of an oral inactivated whole-cell pseudomonas aeruginosa vaccine administered to healthy human subjects.Infect Immun. 2006 Feb;74(2):968-74. doi: 10.1128/IAI.74.2.968-974.2006. Infect Immun. 2006. PMID: 16428742 Free PMC article. Clinical Trial.
-
Development of bronchus associated lymphoid tissue (BALT) in human lung disease: a normal host defence mechanism awaiting therapeutic exploitation?Thorax. 1993 Nov;48(11):1097-8. doi: 10.1136/thx.48.11.1097. Thorax. 1993. PMID: 8296250 Free PMC article. No abstract available.
-
Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease.Cochrane Database Syst Rev. 2017 Jun 19;6(6):CD010010. doi: 10.1002/14651858.CD010010.pub3. Cochrane Database Syst Rev. 2017. PMID: 28626902 Free PMC article. Review.
-
Lymphocyte subsets in bronchoalveolar lavage after exposure to Actinobacillus pleuropneumoniae in pigs previously immunized orally or by aerosol.Lung. 1995;173(4):233-41. doi: 10.1007/BF00181875. Lung. 1995. PMID: 7564482
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
